FdaApplication
ANDA 217511
Identifiers
- fda_app_no: ANDA217511
Properties
| Property | Value |
|---|---|
| applicant_name | INGENUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2023-07-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE | 140MG;125MG;125MG | CAPSULE;ORAL |
1 product